Quantinuum (NASDAQ:QNT – Get Free Report) had its target price decreased by research analysts at Needham & Company LLC from $100.00 to $60.00 in a report released on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC‘s price objective would suggest a potential upside of 101.21% from the company’s previous close.
Several other research analysts also recently weighed in on QNT. Sanford C. Bernstein restated a “hold” rating on shares of Quantinuum in a report on Wednesday, August 12th. Weiss Ratings began coverage on Quantinuum in a research report on Monday, August 31st. They issued a “sell (d)” rating for the company. Jefferies Financial Group set a $85.00 price objective on Quantinuum in a research note on Wednesday, August 12th. Cantor Fitzgerald cut their price objective on shares of Quantinuum from $90.00 to $55.00 and set an “overweight” rating on the stock in a report on Friday. Finally, Morgan Stanley raised shares of Quantinuum from an “equal weight” rating to an “overweight” rating and cut their price objective for the stock from $78.00 to $62.00 in a report on Thursday, October 15th. Thirteen analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $88.46.
View Our Latest Stock Report on Quantinuum
Quantinuum Price Performance
Shares of NASDAQ:QNT opened at $29.82 on Friday. Quantinuum has a twelve month low of $28.31 and a twelve month high of $86.79. The stock’s 50 day moving average price is $43.74. The firm has a market capitalization of $7.85 billion and a price-to-earnings ratio of -106.50.
Quantinuum (NASDAQ:QNT – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.99) by $0.70. The firm had revenue of $9.05 million during the quarter. As a group, research analysts anticipate that Quantinuum will post -4.76 EPS for the current year.
Hedge Funds Weigh In On Quantinuum
Several hedge funds have recently modified their holdings of the company. Wellington Management Group LLP bought a new position in shares of Quantinuum during the 2nd quarter worth approximately $92,418,000. HBK Investments L P purchased a new position in shares of Quantinuum in the 2nd quarter worth approximately $14,669,000. BlueCrest Capital Management Ltd bought a new position in shares of Quantinuum in the second quarter valued at approximately $14,304,000. McGuire Investment Group LLC grew its holdings in shares of Quantinuum by 1,892.4% in the third quarter. McGuire Investment Group LLC now owns 57,360 shares of the company’s stock valued at $2,757,000 after acquiring an additional 54,481 shares in the last quarter. Finally, Readystate Asset Management LP bought a new position in shares of Quantinuum in the second quarter valued at approximately $4,111,000.
Trending Headlines about Quantinuum
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Raised revenue outlook and strong growth: Third-quarter revenue increased 233% year over year, and Quantinuum raised its FY2026 revenue outlook. It also reported a loss of $0.29 per share, narrower than the $0.99 loss analysts expected. Quantinuum Q3 results and outlook
- Positive Sentiment: Improving commercial traction: The company said platform adoption rose nearly 20% quarter over quarter, job submissions increased tenfold year over year, and it secured its largest cloud agreement to date, alongside a hyperscaler agreement and an Oracle beta launch. Quantinuum Q3 results and outlook
- Positive Sentiment: Broker sentiment is favorable: Wall Street brokerages collectively rate QNT “Moderate Buy,” which may support investor confidence. Quantinuum analyst rating
- Neutral Sentiment: Long-term technology roadmap: Quantinuum outlined Nexus, a developer platform intended to connect application development with its hardware, including the Apollo fault-tolerant system planned for 2029. The roadmap offers potential but depends on future execution. Nexus roadmap announcement
- Negative Sentiment: Losses persist: Despite beating the quarterly EPS estimate, QNT remained unprofitable, reporting a $0.29-per-share loss. Continued losses could weigh on investor sentiment as the company works to scale its business. Quantinuum quarterly earnings report
Quantinuum Company Profile
Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.
Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.
Featured Stories
- Five stocks we like better than Quantinuum
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
